1. Treatment with JQ1, a BET bromodomain inhibitor, is selectively detrimental to R6/2 Huntington's disease mice. (7th November 2019) Authors: Kedaigle, Amanda J; Reidling, Jack C; Lim, Ryan G; Adam, Miriam; Wu, Jie; Wassie, Brook; Stocksdale, Jennifer T; Casale, Malcolm S; Fraenkel, Ernest; Thompson, Leslie M Journal: Human molecular genetics Issue: Volume 29:Number 2(2020) Page Start: 202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗